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Abstract
  Patients suffering from tissue hypoxia and claudication due to arterial occlusion, such as those dealing 
with Peripheral Arterial Occlusive Disease (PAOD), have been the target of numerous therapeutic strategies over 
the past few decades. These patients demonstrate inadequacies both in the volume of their collateral circulation as 
well as in the ability of the vessels to dilate in response to increases in metabolic demand. While much research 
has looked into increasing the size of the collaterals, an alternative strategy includes exogenous manipulation of 
the vasodilatory capacity of the vessels. It has been fairly well established that there is a change in vasoactivity 
in response to elevated shear stress and during the outward remodeling phase, but the extent of this impairment 
as well as the pathways responsible for it are poorly understood. Therefore, an effective remedial strategy would 
include restoration of typical vasoactivity to the collaterals while they undergo arteriogenesis. This study aimed to 
determine the impact of vascular occlusion on vascular reactivity through femoral artery ligation and functional 
vasodilation assessments. Following ligation of the artery, luminal diameter measurements were taken in the mus-
cular branch artery at 3 and 7 days post-occlusion using intravital microscopy. At the day 3 time point, there is 
no difference between the resting diameters (45.9±10.92µm control, 57.13±14.43µm experiment) nor between the 
dilated diameters (101.04±29.77 µm control, 104.72±20.76 µm experiment). One week following the ligation, there 
is a difference between the control and experiment diameters both at resting (50.19±12.36 µm control, 67.47±13.51 
µm experiment) and dilated (95.95±16.45 µm control, 119.05±18.59 µm experiment). Finally, a comparison of the 
percent change over resting diameter between the two time points trends toward less reactivity in the experimental 
limbs, but with no statistical significance, suggesting that the vasomotor tone is not impaired. Due to slight varia-
tions between this research and previous work, further investigation is requisite to establish solid evaluations of 
vascular reactivity in response to arterial occlusion.
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Introduction
 Critical Limb Ischemia (CLI) is characterized 
by chronic resting pain, claudication, superficial ul-
cers, and/or gangrene directly related to arterial occlu-
sions.1 These occlusions are the result of atherosclerotic 
plaque deposits on the lumen of conduit arteries. While 
these depositions can be attributed to atherogenesis, 
advanced stages of this response due to acute and severe 
endothelial inflammation can force the progression of 
plaque buildup to a critical state. At this state, the lu-
men becomes completely occluded and blood is rerouted 
through the collateral circulation. The physiological 
consequence of such a diseased state is that the target 
tissue becomes hypoxic.2 This deficiency in metabolic 
exchange and the formation of multiple acute athero-
sclerotic lesions are indicative of Peripheral Arterial 
Occlusive Disease (PAOD). Major risk factors for this 
disease include smoking, high cholesterol, diabetes, high 
blood pressure and genetic predisposition.2 Because of 
the many factors that contribute to the development of 
this disease, it is estimated to effect between 8-10 mil-
lion Americans, and the prevalence is expected to rise 
worldwide with the aging population.3, 10 
 The etiology of PAOD begins with the formation 
of atherosclerotic plaque (see Figure 1). The buildup of 
this plaque is due to the presence of turbulent shear stress 
at the vessel wall, leading to an activated endothelium.4 
When major conduit arteries become chronically ste-
nosed to the point that downstream tissue cannot receive 
Figure 1 - Cross-sectional view of arterial lumen being occluded by 
plaque deposits. Atherogenesis leads to the narrowing of arteries 
due to the buildup of this atherosclerotic plaque.
Figure 2 - Progression of Arteriogenesis from occlusion to 
collateral enlargement.
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a sufficient amount of nutrients, the tissue will become 
necrotic unless collateral vessels can support the change 
in flow conditions.   
 The current methods for treating PAOD patients 
suffering from CLI include surgical bypass, endovas-
cular procedures and in extreme cases amputation.1 
Specific treatment options can range from non-invasive 
techniques such as prescribing an exercise regimen to 
more extreme methods such as surgical intervention 
including aortofemoral bypass surgery and angioplas-
ty. Treatment decisions for these patients are made on 
an individual basis and take into account the patient’s 
age, progression of the disease, surgical risk and life 
expectancy.1 Currently, there have been no efficacious 
demonstrations of pharmacologic or biologic therapeutic 
treatments for the disease.1 Therefore, there is a dire 
necessity for the development of a biological- and/or 
physiological-based treatment. 
 A physiological adaptation to arterial occlusions 
is the enlargement of collaterals due to increases in blood 
flow and shear rate through the collateral circuit (see 
Figure 2). These increases are due to a reduction in 
distal pressure, allowing for a higher pressure gradient 
throughout the alternate pathways. Arteriogenesis is 
characterized by the formation of functional collateral 
arteries arising from pre-existing arterio-arteriolar anas-
tomoses.5 It is important to note that that morphological 
Figure 3 - Anatomy of artery, vein and capillary. 
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changes to these collateral vessels is solely due to in-
creased shear stress and enhanced pressure gradients. 
Tissue ischemia does not appear to affect arteriogenesis, 
partly because the vessels that are collaterally enlarging 
are typically not surrounded by hypoxic tissue.6 
 To fully appreciate this vascular response, it 
is necessary to understand the anatomy of the vessels 
themselves and the pathways responsible for vascular 
reactivation. Vasoactivity is determined by the smooth 
muscle cell layer, which responds to signals from the 
inner endothelial cell layer, neurons and hormones (see 
Figure 3).15 This layer of smooth muscle cells is much 
thicker in the arterial than the venous system (see Figure 
4), and is a large contributor to changes in blood pres-
sure and flow control. This endothelial cell layer is the 
innermost tunic, and is the only portion of the vessels in 
direct contact with blood and blood components. Once 
these cells experience an increase in shear stress and 
an elevated pressure gradient during arteriogenesis, 
they release paracrine signals to initiate the remodel-
ing process. 
 The requisite pathways for vasodilation can arise 
through endothelial cell activation, nervous stimulation, 
interstitial metabolites, endocrine factors and changes 
in vascular pressure. For example, The release of nor-
epinephrine from local neurons will result in smooth 
muscle cell activation and ultimately, vasoconstriction.15 
Similarly, the synthesis of nitric oxide (NO) from ni-
tric oxide synthase (NOS) produced in the endothe-
lium will result in smooth muscle cell relaxation and 
vasodilation.15.  
 It has been postulated that exogenous manipula-
tion of vessel reactivity could have a positive effect on 
PAOD.7 Therapeutic arteriogenesis could relieve some of 
the symptoms caused by CLI by stimulating collateral 
enlargement, effectively increasing the size of available 
alternative flow paths. Some studies have suggested the 
use of growth factors such as granulocyte-macrophage 
colony-stimulating factor to stimulate the growth of 
certain collaterals.8 However, this therapeutic strategy 
has largely failed clinically due, in part to an inadequate 
understanding of the timeline surrounding the interplay 
between collateral enlargement and vascular reactivity.
 In order for therapeutic arteriogenesis to be an 
effective remedial treatment strategy, it is foremost im-
portant to develop an understanding of the chronology 
Figure 4 - Histological stain for endothelial cells showing the 
differences in smooth muscle thickness between artery and vein.
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of vascular growth and repair. The time course for col-
lateral growth has been established by Glass et al. and 
Hoefer et al. to be 10 days post occlusion.9 However, 
there is no indication of the extent to which the arteri-
oles have enlarged. In particular, it is unclear whether 
this time period of 10 days is sufficient to allow these 
alternate flow paths to remodel to the point at which 
they completely mimic a mature vessel
 In addition to a chronological assessment of vas-
cular repair, it is essential to understand the transient 
impairment to vascular reactivity in response to arterial 
occlusion. It has been observed that patients experi-
encing large occlusions resulting in reduced metabolic 
exchange at the capillary level exhibit a reduction in 
vasoactivity.11 This offers a unique therapeutic strat-
egy – to restore or enhance the natural vasoreactivity 
of the blood vessel, that it may react to the changes in 
metabolic demand more effectively. To develop such a 
strategy however, requires an enhanced understanding 
of the mechanisms for abnormal vasoactiity in response 
to arterial stenosis. 
 The Microcirculation and Tissue Repair lab at 
Cal Poly has investigated a number of mechanisms to 
explain this reduction in vasoactivity, including sur-
gical models assessed using brightfield microscopy, 
microscan equipment, and histological analysis. Some 
groups have considered ischemic surgical models to 
characterize both angiogenesis and arteriogenesis. The 
result of atherogenesis is a decrease in vascular activ-
ity at 7 and 14 days post occlusion. The focus of this 
paper is to delineate the time course of the decrease in 
vasoactivity due to the onset of collateral enlargement. 
To accomplish this, an additional time point (3 days post 
ligation) has been added to gain a better understanding 
of the remodeling process throughout a recovery period 
of 2 weeks. 
 It is hypothesized that a significant degree of col-
lateral enlargement will have occurred one week follow-
ing the ligation, and that the dilative ability of the vessel 
(percent increase from resting) will not differ from a 
control vessel. At day 3 however, we expect to see no 
significant change in luminal diameter, but a statistical 
difference between the experiment and control vessel’s 
ability to respond to changes in metabolic demands.
Methods
Husbandry
 Two-month-old male C57Bl/6 mice were used 
for all time points in this study. All husbandry proce-
dures maintained through the course of this research 
strictly adhered to The Guide for the Care and Use of 
Laboratory Animals (commonly referred to as “The 
Guide”) per National Institute of Health (NIH) regula-
tions, Office of Laboratory Animal Welfare (OLAW) 
mandates and all Institutional Animal Care and Use 
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Committee (IACUC) protocols. Each mouse was housed 
together in groups of four inside a microisolator cage lo-
cated in the Vivarium at Cal Poly. Food pellets and water 
were provided ad libitum along with enrichment items 
such as a house, tubes, and nesting material. Cages were 
inspected daily for mouse health and mold accumulation 
and were changed using aseptic technique, on average, 
every two weeks. The room housing the microisolator 
cages for all of the mice was maintained between 68-72 
°F and was set to a 12 hour light/12 hour dark schedule. 
Following the initial survival surgery, the animals were 
housed in a separate cage to discourage barbering and 
other detrimental behavior. 
Surgical Procedures
 Two distinct procedures, including a surgery and 
a dissection, were performed throughout this study (the 
detailed protocol for each can be found in Appendices A 
and B, respectively). Each mouse included in the study 
first underwent a proximal saphenous artery ligation 
followed by an intravital microscopy procedure at a 
given time point later (either 3 or 7 days). 
  In preparation for the ligation surgery, a sterile 
pack along with the surgical instruments was placed in 
an autoclave. The mouse was then placed into an induc-
tion chamber and anesthetized with a 1-3% Isoflurane/
Oxygen gas mixture at a flow rate of 0.5-1.0 LMin-1. 
Once the mouse was determined to be at a surgical 
plane of anesthesia (respiratory rate of 1-2 breaths per 
second), the anesthetic gas was redirected to the surgi-
cal prep bench and the animal was placed in a supine 
position with its nose inside the nose cone (see Figure 
5). The surgical area was prepared by first removing 
the hair on the medial aspect of both hindlimbs using 
hair clippers followed by administration of depilatory 
cream. Once clear of all hair, the hindlimbs were sani-
tized using Nolvasan and aseptic technique. The anes-
thetic gas was then redirected to the surgical bench and 
the animal was placed on a large gauze pad and laid 
on top of a heat pad under the brightfield microscope. 
A rectal thermometer was inserted to provide internal 
body temperature feedback to the heat pad to maintain 
Figure 5 - Surgical setup showing mouse in supine position with 
hindlimbs taped apart and nose directed into the nose cone to 
receive a continuous supply of anesthetic gas. 
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a temperature close to 35 °C. Additionally, PuraLube® 
Veterinary Ointment was administered to each eye to 
prevent desiccation. Both hindlimbs were outstretched 
and fixed to the gauze pad using medical tape. Once 
under the dissection scope, appropriate sterile clothing 
was donned (including mask, hair net, sterile gloves and 
isolation gown/surgical scrubs) and the sterile pack and 
instruments were opened. 
 The first incision was made on top of and parallel 
to the saphenous neurovascular bundle using standard 
pattern forceps and iris scissors. The incision was ex-
tended from near the knee up to the fat pad and blunt 
dissected using the S&T forceps. Note that a solution 
of sterile Phosphate Buffered Saline was continuously 
administered to the surgical site to prevent desiccation. 
Once adequately exposed, all connective tissue includ-
ing the fat pad was blunt dissected to ensure optimal 
viewing of the ligation site. It was then necessary to 
remove the entire fat pad. To accomplish this, the adi-
pose was dissected away from the abdominal wall and 
on either side of the epigastric artery/vein pair and was 
then cauterized. The saphenous artery was then isolated 
from the vein and nerve using a pair of 5-45 forceps. 
Once adequately dissected, a suture was tied around the 
vessel with a double knot. The incision was then sewn 
closed with 6-0 polypropylene suture using a spiral-
pattern suture technique, and was anchored at both ends 
with surgeon’s square knots. 
 A sham surgery was then performed on the 
contralateral limb in order to provide adequate control 
measurements. This surgery consisted of the same inci-
sion above and parallel to the saphenous neurovascular 
bundle, blunt dissection of all connective tissue (exclud-
ing cauterization and resection of the fat pad) and wound 
closure using the spiral-pattern suture method. 
 Following this surgery, a subcutaneous injection 
of an analgesic (buprenorphine, 0.075 mg/kg) was ad-
ministered. The animal was placed in a heated recovery 
bin until ambulatory, at which time it was placed in a 
new microisolator cage in the Vivarium. 
 The follow-up experiment for these animals 
included analysis of vascular diameter in the muscu-
lar branch using intravital microscopy. This imaging 
technique uses sidestream darkfield imaging to observe 
details on the order of a couple hundred micrometers. 
 Depending on the time point of the study, the ani-
mals were allowed to recover for a period of 3 or 7 days. 
At this point, each mouse was brought back to the sur-
gery suite, anesthetized and the surgical area prepared 
as previously described. Each hindlimb was opened 
to sufficiently expose the muscular branch. While still 
under the brightfield microscope, two (stimulus and 
ground) tungsten needle electrodes were set in place. 
The positive lead was inserted under the skin or into the 
adipose tissue and acted as the ground. The negative lead 
was rested on the tissue surface, orthogonal to the motor 
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end plate of the gracilis muscle (this effectively creates 
a negative extracellular potential, forcing an action po-
tential within the muscle fibers). Using LabChart soft-
ware (AD Instruments), a test excitation was performed 
to ensure accurate placement of the electrodes. After 
administering enough mineral oil to coat the exposed 
area, the MicroVision Medical MicroScan scope was set 
in place on top of the profunda. Following microscope 
placement, a small amount of plastic wrap was placed 
over the exposed tissue and a rest period of 30 minutes 
was taken to provide ample time for the vasculature to 
return to resting state. 
 An initial 10s video of the muscular branch ar-
tery was taken using MicroVision Medical AVA soft-
ware. The gracilis muscle was then stimulated for 90s 
at a frequency of 8Hz, duration of 500µs and amplitude 
of 1mA. Immediately following this stimulation, an ad-
ditional video was recorded of the profunda artery along 
with subsequent videos every 2 minutes until the vessel 
returned to baseline. For each video taken, a stabilized 
video was constructed which filtered out the respira-
tory movement of the animal. Using this stable video, 
intraluminal diameter measurements were taken for the 
resting and stimulated vessel along with measurements 
as the vessel returned to its resting state. 
 The decision to perform the MicroScan measure-
ments first on the experimental or sham limb was made 
at random to increase the robustness of the research. 
Immediately following this procedure, the animal was 
sacrificed via cervical dislocation. 
 Data analysis was performed using Microsoft 
Excel. The data set for each individual surgery (includ-
ing resting, dilated, and return to resting diameters 
for sham and experimental limbs) was imported into 
a spreadsheet. The mean, standard deviation, standard 
error, and percent change from resting values were cal-
culated for each hindlimb. Using these values, a student’s 
t-test was performed to examine significant differences 
between the data sets. A p-value ≤ 0.05 represented a 
statistically significant difference between groups with 
a confidence level of 95%. The data was graphically 
represented using a bar chart including error bars rep-
resenting ± standard deviation. 
Results
 To ensure proper surgical technique throughout 
all aspects of this procedure (including saphenous ar-
tery ligation and microscan measurements), an initial 
D7 pilot study was performed. Additionally, this study 
allowed for verification of the collected data set against 
previously performed intravital measurements thought 
to be accurate. In this way, the data collected can be 
translated across many similar studies to suggest trends 
and show significance without the danger of using inac-
curate diameter measurements. 
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 The pilot study presented in this paper was 
conducted in a similar manner to the d7 experiments 
performed by another member of the Microcirculation 
lab at Cal Poly, including operation on both the sham 
and “experimental” limb (no ligation placed around 
the artery), a recovery period of 7 days and stimula-
tion and measurement of the luminal diameter for both 
hindlimbs. There was no statistical difference between 
the control and experimental resting diameters or be-
tween the control and experimental functional vasodila-
tion (see Figure 6). This is to be expected, as there was 
no experimental difference between either limb for this 
study. Additionally, there was a significant difference 
between the resting and dilated valued for both sham 
and experimental limbs. These results support previous 
diameter measurement studies, which have found a typi-
cal stimulated luminal diameter to be 200% of resting 
(see Figure 7). A typical stimulation and relaxation curve 
(see Figure 8) for the muscular branch artery shows an 
initial, statistically significant spike in luminal diameter 
followed by a gradual return (on the order of 5-8 µm 
min-1) to resting diameter over a period of 8-12 minutes. 
 Upon verification of gathering reproducible data, 
vessel functionality following occlusion was investi-
gated. Two time points were investigated – 3 and 7 days 
Figure 6 - Results of the functional vasodilation pilot study. 
No statistical difference was found between the “sham” and the 
“experimental” hindlimbs. 
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post ligation. Using the intravital microscope, luminal 
diameter measurements for six induced ischemic ani-
mals was collected. 
 The protocol for this study consisted of ligation 
placement in the experimental limb and a sham surgery 
for the control. Following one week of recovery time, an 
intravital microscopy procedure was performed for both 
hindlimbs (see Figure 9). This study showed a significant 
difference between the experimental and control resting 
diameters with a p-value of 0.0434 (control 50.19±12.36 
µm, experimental 67.47±13.51 µm). Likewise, there was 
a significant difference between the experimental and 
control dilated diameters with a p-value of 0.0458 (con-
trol 95.95±16.45 µm, experimental 119.05±18.59 µm). 
Both of these differences are indicative of vascular re-
modeling due to the ligation over the recovery period 
of 7 days. 
 As an additional check to ensure consistency 
among the data sets, a comparison of the percent change 
from resting diameter for resting and dilated diameters 
at both D3 and D7 was prepared. The data shows that 
the muscular branch in the experimental limbs at both 
time points was able to dilate to roughly 90% over the 
resting value (see Figure 12). Although not statistically 
different from the experimental limbs, the control limbs 
for both time points was able to dilate to a greater extent 
of nearly 120% above resting values. This trend showing 
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a difference in vasoreactivity suggests that, due to the 
remodeling process occurring post-ligation, the vessels 
are less able to react to changes in metabolic demand 
than non-treated vessels.
 Following the D7 procedure, an additional time 
point was necessary to assess vascular remodeling and 
behavior trends throughout the process of collateral en-
largement. Because later time points (D14, D28) had 
already been characterized or were currently under in-
vestigation, a day 3 model was utilized. This model 
mimicked the previous protocol for arterial ligation and 
microscan measurements, however, following the initial 
ligation surgery the animal was allowed a recovery pe-
riod of 3 days. The results of this study showed no sta-
tistical differences between the sham and control limbs 
(see Figure 10). The control resting (45.9±10.92 µm) and 
the experimental resting (57.13±14.43 µm) diameters 
were not different, with a p-value of 0.1596. However, 
the data does show a trend that the luminal diameter is 
beginning to enlarge 3 days following upstream ligation. 
The control dilated (101.04±29.77 µm) and the experi-
mental dilated (104.72±20.76) diameters also exhibited 
no statistical significance between the groups. This lack 
of statistical significance shows that at 3 days following 
occlusion of a feed artery, collateral enlargement has 
not begun or progressed to the point at which there is a 
significant difference between the vessel diameters. 
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Discussion
 Upon characterization of vessel phenotype and 
reactivity at both time points, a comparison between 
each group was made. This assessment of the relation-
ship between the D7 and D3 studies provides a more 
robust and coherent representation of the remodeling 
process (see Figure 11). An initial comparison of the 
control limbs was made between both time points to es-
tablish a sense of congruency throughout the data. There 
was no significant difference between the 3-day and 
7-day resting and dilated diameters for the control limbs. 
Likewise, there was no statistical difference between the 
time points for the experimental limbs. Although the 
data did not support any statistical significance, there are 
slight trends suggesting enlargement due to remodeling. 
Specifically, the luminal diameter for the experimental 
resting limb at D3 is less than the diameter for the same 
limb at D7 (~10µm). Likewise, the D7 experimental di-
lated diameter was larger than the diameter at D3. Both 
of these observations, while not significant, show a trend 
toward increasing luminal diameter at later time points. 
This trend is to be expected, as an increased period of 
remodeling will of course lead to more robust collateral 
enlargement.
 Arterial occlusion leading to tissue hypoxia and 
ischemia is a complex disease that ultimately results in 
vascular dysfunction, both in terms of vascular growth 
and vasoreactivity to changes in metabolite concentra-
tion.12 While many current investigations into PAOD are 
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Figure 12 - Mean luminal diameter percent change from baseline 
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points.  
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concentrating on establishing protocols for increasing 
vascular growth and repair, few researchers are looking 
into the possibilities of treatments surrounding enhanced 
vasoreactivity.13,14 These changes in vasomotor tone have 
been shown to dramatically affect the recovery from an 
ischemic event.3 To evaluate the extent to which vasoac-
tivity effects an individual’s ability to handle vascular 
occlusions, this study investigates abnormal vasoac-
tivity due to upstream occlusion in order to form the 
foundational knowledge for the ventual development of 
therapeutic strategies to treat PAOD.
 It was initially necessary to establish consistent 
data collection methods to ensure that the information 
did not vary from researcher to researcher. This was 
accomplished through the use of a pilot study, which pro-
vided practice in collecting data through measurement 
of luminal diameter in the muscular branch using intra-
vital microscopy. The results of the pilot study showed 
no statistical difference between the limbs along with 
a luminal diameter percent change that was consistent 
with previous work. Because of the reliability of this 
data, it can be assumed that the methods employed for 
data collection accurately adhere to the provided proto-
col, and that any differences found in the future studies 
are due to the physiological response to the ligature and 
not experimental error. 
 The following study included collection of lumi-
nal diameter measurements in the profunda of the left 
hindlimb 7 days following the ligation of the proximal 
saphenous artery. Upstream occlusion of feed arteries 
such as the saphenous artery lead to the shunting of blood 
through alternate or collateral pathways. This increase in 
mass flow rate, along with changes in the pressure gradi-
ent, lead to the enlargement of the cross-sectional area of 
the lumen of these collateral arteries. This study showed 
a statistically significant difference between the resting 
values of the experimental and control limbs (p-value of 
0.0434). There was also a significant difference between 
the dilated diameters for the experimental and control 
limbs (p-value of 0.0458). These differences show that 
one week following occlusion of upstream arteries, the 
vessel has begun to remodel and enlarge to handle the 
changes in shear stress. 
 Although this study does correlate with previ-
ous D7 studies and confirm the incidence of collateral 
enlargement at this time point, there is a major difference 
between the confidence levels for each study. The previ-
ous work on collateral enlargement 7 days post ligation 
concluded that there was indeed a statistical difference 
between the luminal diameters for the experimental 
and sham limbs, but with a p-value of 4.997E-6. This 
suggests that we can be more than 99% confident that 
collateral enlargement has taken place. However, the 
p-value obtained in this study (~0.045 for both resting 
and dilated diameters) suggests only 95% confidence. 
This incongruence between the data can be attributed to 
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slightly inconsistent surgical methods between research-
ers, both for the ligation and the microscan surgeries. 
Until the completion of this investigation, each experi-
menter followed the surgical protocol under his/her own 
discretion. Upon observation of the variation in the data 
sets between the same experiments, it became necessary 
for each person performing a study to scrutinize others’ 
surgeries. By doing so, it is possible to obtain informa-
tion about minute details of the surgery that each person 
is inadvertently performing differently. For example, it 
was observed that there were inconsistencies between 
researchers in the method and order of electrode place-
ment on the gracilis muscle; sometimes the electrodes 
were placed using the brightfield microscope to ensure 
correct placement, or they were pressed too firmly on 
top of the tissue. Likewise, there were discrepancies 
with how proximal a location the ligature was placed 
and how well the incision was sutured closed. Each of 
these irregularities between researchers could lead to 
decreased collateral enlargement, possibility of infec-
tion, and decreased functional vasodilation. 
 In addition to dissimilarities between discrete 
surgical procedures across researchers, variations in the 
stimulation parameters led to distinct dilation responses. 
In terms of the resection surgery, a pulse duration of 
200 µs resulted in no dilation response whereas a 500 
µs duration led to a robust response when performed 
on separate animals. If both of these parameters were 
tested on the same animal, the larger pulse duration led 
to a negligible dilation response. Whether or not this 
(lack of) response was due to muscle fatigue is poorly 
described, but did provide us with an appropriate pulse 
duration of 500 µs for use in this study.
 Finally, a time point of 3 days post-occlusion was 
included. The protocol for this study mimicked that of 
the D7, except that the recovery period was shortened to 
3 days following the initial surgery. The results of this 
study only partially supported the initial hypothesis. 
There was no evidence of a statistical difference between 
the experiment and sham limbs for either the resting or 
dilated measurements (p-value of 0.1596 and 0.8092, 
respectively). This information does support the initial 
estimate that there would be no observable or significant 
change in vessel cross-sectional area at this time point. 
However, there was also no evidence of a difference 
between the vasoactivity of the experiment and control 
vessels, suggesting that the experimental vessel (which 
should be enlarging due to increases in shear stress) is 
still able to function similar to a typical vessel. Based 
on this information, it is appropriate to conclude that 
3 days following occlusion of feed arteries, collateral 
vessels are only beginning to react to the change in flow 
conditions; a negligible amount of collateral enlargement 
has occurred in these vessels, and the vasoactivity of 
the collateral has been preserved. 
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 Based upon previous work, the collateral vessels 
supplying the gracilis muscle have a dilative capacity 
close to 200% that of resting. The data collected for this 
study relating to the D3 and D7 time points both exhib-
ited close to 220 percent change from resting. This 20% 
disparity can most likely be attributed to recruitment of 
extraneous muscle groups. Specifically, muscles in ad-
dition to the gracilis (such as the gastrocnemius, and/or 
the abductors and adductors on the posterior and anterior 
aspects of the hindlimb, respectively). This only rein-
forces the importance of accurate and precise electrode 
placement on the hindlimb. As previously stated, these 
slight discrepancies between this study and previous 
studies necessitate the development of standard surgical 
and experimental practice across researchers, ensuring 
consistent data. 
 The experimental limbs both demonstrated a 
slight reduction in the percent change from resting. 
Although not statistically significant, this reduction to 
near 180% of resting diameter reveals a trend that sug-
gests a retarded ability of the ligated vessel to dilate in 
response to changing metabolic demands. This impaired 
vasodilation is consistent with our knowledge of the arte-
riogenic process, but the extent to which the vasoactivity 
is compromised is still questionable. Previous studies 
have demonstrated a reduction to 140% change from 
resting diameter for the vessels at the D7 time point. 
Again, this inconsistency can be correlated to imprecise 
stimulation of the gracilis muscle. As such, further re-
search is necessary to establish any sound evidence of 
a statistically significant change to vasoactivity of the 
vessels. 
 Additional research is necessary to establish an 
appropriately complex and detailed model of the in-
hibition to vascular reactivity in response to luminal 
occlusion. Specifically, additional time points need to 
be incorporated to provide adequate representations of 
the progression of the diseased state, along with varying 
methods for initiating a vasodilative response. 
 Because the D3 time point showed no significant 
change in the luminal diameter along with no change 
to ability of the vessel to dilate, a D5 study is recom-
mended to study the changes in vascular morphology 
and physiology between 3 and 7 days post occlusion. 
Additionally, the progression of arteriogenesis should 
be observed past one week. A two and three week time 
point is suggested to provide adequate representations of 
the progression of the vessel from occlusion to complete 
repair. With the addition of data from these studies, it 
would be possible to establish a robust description of the 
changes to vascular reactivity from onset to complete 
maturation. 
 At each of these time points, it is also necessary 
to understand how variations in the mechanism for ini-
tiating vasodilation affect the inhibition to vasoactivity. 
The electrical stimulation of the gracilis muscle used 
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in this study should be carried out at each of the other 
time points to create an all-inclusive study of the effect 
of electrode stimulation directly to the gracilis muscle 
on the vasoactivity of a muscular branch experiencing 
increases in mass flow rate. Akin to this study, direct 
stimulation of the nerve that innervates the gracilis 
muscle would provide nice contrast from the previous 
needle electrode stimulation study. To be consistent, 
3,5,7,14 and 21 days post-occlusion studies should be 
conducted using nerve stimulation. If the discrepan-
cies between previous work were indeed due to issues 
with electrode placement, then stimulation of the nerve 
should eliminate these errors and provide a more accu-
rate picture of the arteriogenic process in the profunda. 
 Along with direct electrical stimulation of the 
gracilis muscle or the nerve innervating this muscle, the 
effects of chemical stimulation of vasodilation should 
be studied. Specific pharmacologic agents to be used 
include acetylcholine (Ach), which is an endothelium-
specific agent that results in vasodilation by stimulating 
the production of nitric oxide (NO) from endothelial 
nitric oxide synthase (eNOS), and sodium nitroprusside 
(SNP), which facilitates smooth muscle relaxation by do-
nating NO to the smooth muscle cell receptors. Both of 
these chemical agents should be included in day 3,5,7,14 
and 21 superfusion studies. These studies will mimic 
the surgeries and microscan experiments conducted in 
the mechanical stimulation studies, but will replace the 
electrodes with these Ach or SNP. These agents will be 
administered using a superfusion setup that will provide 
a constant flow of Ach or SNP over the exposed portion 
of the hindlimb while the measurements are being taken. 
 The combination of both electrical and chemical 
stimulation of vasodilation over each of the established 
time points will provide detailed model of arteriogenesis 
due to arterial occlusion and aid with the development 
of strategies to manipulate these pathways to promote 
collateral enlargement and the appropriate magnitude 
of vasodilation. 
Conclusion
 It is important to realize that the animal mod-
els used in this research were both young (around 2 
months old) and healthy. This issue is critical because 
the majority of patients suffering from PAOD or other 
types of extreme atherosclerotic occlusion disorders are 
typically a part of the aging population. Use of young 
and healthy animals models is an excellent first attempt 
at understanding the mechanisms for vasomotor disor-
der during arteriogenesis,  but it lends itself to further 
research. Specifically, observation and characteriza-
tion of vascular reactivity in other non-healthy animal 
models would provide sufficient data to extrapolate the 
behavior of the vessels over a wider range of disease 
states. Because all of the data collected in this study 
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came from surgical models of arterial occlusion, future 
animal models should include some genetic modeling, 
such as apolipoprotein E-/- or LDL receptor -/-. 
 Due to the high prevalence of chronic limb isch-
emia and PAOD in elderly patients, the development 
of  novel alternative treatments is a necessity. Potential 
remedies include therapeutic arteriogenesis, which has 
largely failed clinically, or manipulation of vasomotor 
behavior to increase perfusion to ischemic tissues. An 
even more effective treatment strategy would include a 
combination of both of these methods, however a more 
complete understanding of the pathways resulting in 
changes to vascular reactivity is imperative. This re-
search showed a decrease in vasomotor tone during 
arteriogenesis and as such, provides an excellent step-
ping stone for future work in manipulating vasodilation 
to compensate for arterial occlusion.
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Appendix A
Date______________ Hindlimb Ischemia Surgery - Ligation Initials____________ 
 
Mouse Information 
DOB: ____________________  
Sex:______________________   
Tag:______________________  
Genotype/strain: ____________  
Cage:_____________________  
 
Materials 
Sterilize- autoclave or flash autoclave 
____1. Standard pattern forceps (1) 
____2. S&T forceps (2) 
____3. 5-45 forceps (1) 
____4. Iris scissors (1) 
____5. Microdissection scissors (1) 
____6. Castroviejo (1) 
____7. Retractor (1) 
 
Pre-sterilize in autoclave 
____8. cotton gauze (2) 
____9. cotton swabs (12) 
____10. 6.0 silk suture (2 x 1-inch) 
 
Obtained in surgery suite 
____11. sterile Petri dish w/ sterile saline 
____12. sterile gloves 
____13. sterile 7.0 prolene suture 
____14. heat-cautery 
____15. FST heat pad w/ rectal probe 
____16. heat pad 
____17. recovery bin & weigh boat 
____18. depilatory cream 
____19. non-sterile cotton swabs 
____20. non-sterile cotton gauze 
____21. isolation mask & cap 
____22. analgesic (Buprenorphine) 
 
Surgery preparation 
____23. Spray surgery area with Nolvasan 
____24. Weigh animal in weight boat 
____25. Place animal in anesthesia box 
____26. Open the oxygen cylinder and set 
anesthesia-machine flow meter to ~3 l·min-1 
____27. Anesthetize animal w/ 5% isoflurane  
____28. Affix non-rebreathing circuit to bench-top 
with tape  
____29. Reduce flow rate to 0.5-1.0 l·min-1 and the 
isoflurane to 1-3% 
____30. Apply ear tag high on left ear 
____31. Lay animal supine with nose in nose-cone 
____32. Shave hair on the right hindlimb & lower 
abdomen with clippers  
____33. Remove excess hair with depilatory cream 
____34. Spray right hindlimb with Nolvasan 
____35. Return animal to anesthesia box 
 
____36. Apply 4x4 gauze sponge to heat pad to 
protect animal from excessive heat 
____37. Affix non-rebreathing circuit to surgery 
table w/ chemistry clamp 
____38. Lay animal supine on circulating heat pad 
w/ nose in nose-cone 
____39. Insert rectal probe and set thermo-controller 
to 37°C 
____40. Apply veterinary ointment to eyes to avoid 
drying during procedure 
____41. Apply veterinary ointment to anus and place 
rectal probe ~1cm into anus to monitor core-
body temperature 
 
Surgery 
____42. Make a small incision on the middle, medial 
aspect of the left thigh 
____43. Extend the incision up to the abdominal wall  
____44. Blunt dissect the subcutaneous connective 
tissue to maximize surgical exposure 
____45. Use cautery to remove fat pad overlying 
femoral a-v pair & cauterize epigastric av-
pair 
____46. Blunt dissect the femoral artery from the 
neurovascular bundle just downstream from 
the deep femoral branch 
____47. Tie off the femoral artery & vein with 6.0 
silk suture, just downstream to the deep 
femoral branch 
____48. Use 6.0 polypropylene suture to close the 
skin  
____49. Make a small incision on the middle, medial 
aspect of the right thing 
____50. Extend the incision up to the abdominal wall 
____51. Blunt dissect the subcutaneous connective 
tissue to maximize surgical exposure 
____52. Use 6.0 polypropylene suture to close the 
skin  
 
Post-Surgical  
____53. Give the animal an subcutaneous injection 
of buprenorphine (0.075mg/kg) 
____54. Place the animal in the recovery bin, on a 
blue bench cover, above a heat pad and 
allow to recover 
____55. Turn flow meter down to 0, turn off 
isoflurane, and close the oxygen cylinder 
____56. Indicate surgery on cage card  
 
Notes 
_____________________________________________  
_____________________________________________  
_____________________________________________  
_____________________________________________  
Appendix B
Date______________ Microscan Initials____________ 
 
 
Mouse Information 
DOB: _____________________  
Sex:_______________________   
Tag: ______________________  
Genotype/strain: _____________  
Cage: _____________________  
 
Materials 
Instruments 
____1. forceps (2) 
____2. fine forceps (2) 
____3. ultrafine forceps (1) 
____4. fine scissors (1) 
 
Obtained in surgery suite 
____5. Petri dish w/ sterile saline 
____6. gloves 
____7. FST heat pad w/ rectal probe 
____8. heat pad 
____9. non-sterile cotton swabs 
____10. non-sterile cotton gauze 
 
Surgery preparation 
____11. Weigh animal in weight boat 
____12. Place animal in anesthesia box 
____13. Open the oxygen cylinder and set anesthesia-
machine flow meter to ~3 l·min-1 
____14. Anesthetize animal w/ 5% isoflurane  
____15. Reduce flow rate to 0.5-1.0 l·min-1 and the 
isoflurane to 1-3% 
____16. Lay animal supine with nose in nose-cone 
____17. Lay animal supine on circulating heat pad w/ 
nose in nose-cone 
____18. Insert rectal probe and set thermo-controller to 
37°C 
____19. Apply veterinary ointment to eyes to avoid 
drying during procedure 
 
Measurement preparation  
____20. Make a small incision on the middle, medial 
aspect of the left thigh 
____21. Extend the incision up to the abdominal wall  
____22. Blunt dissect the subcutaneous connective 
tissue to maximize surgical exposure 
____23. Maximize visibility of muscular branch 
____24. Place wooden end of cotton swab on knee and 
secure to allow for isometric contraction and 
insure that the hind limb is level 
____25. Place black electrode on the center of the 
gracilis anterior and secure electrode 
____26. Place red ground electrode at the lateral aspect 
of the knee underneath the skin. Secure 
electrode. 
____27. Place mineral oil over exposed areas 
 
 
Microscan  
____28. Place microscan in stand and insure proper 
connectivity to computer.  
____29. Open AVA instruments and create new folder 
containing the date of procedure and make this 
the directory save location. 
____30. Select capture on AVA main menu for 
microscan imaging  
____31. Label patient I.D. with the number of patient 
first followed by mus for experimental hind 
limb or sham for control hind limb. 
EX: 25mus 
____32. Locate muscular branch and adjust microscan 
for best resolution. 
____33. Allow 30 minute time period to pass before 
taking measurement. 
____34. Capture video file of muscular branch to 
capture resting diameter 
____35. Open Lab Chart 6 open file in blood pressure 
measurement folder then open microscan 
default settings.  
____36. Set frequency to 8Hz, duration to 500µs, and 
1mA 
____37. Turn on stimulator panel 
____38. Stimulate muscle for 90 sec 
____39. Immediately capture video and continue to 
capture every two minutes until vessel has 
returned to resting diameter 
____40. Perform same procedure on control limb 
 
Analysis 
____41. Open analysis section in AVA and open file of 
interest 
____42. Set Frames from 0 to 160 and stabilize file 
____43. Analyze vessel diameter by manually drawing 
diameter and chaining sections together 
____44. Record results in provided table 
 
Post-Surgical  
____45. Cervical dislocation to euthanize animal  
 
Notes 
_______________________________________________  
_______________________________________________  
_______________________________________________  
_______________________________________________  
_______________________________________________  
_______________________________________________  
_______________________________________________  
  
 
 
 
 
 
 
 
